Biogen to present new SMA data at MDA Clinical & Scientific Conference and SMA Europe Congress

Reuters
03/05
Biogen to present new SMA data at MDA Clinical & Scientific Conference and SMA Europe Congress

Biogen Inc. will present new data and program updates from its spinal muscular atrophy research portfolio at the 2026 Muscular Dystrophy Association Clinical and Scientific Conference (March 8-11, 2026) and at the 5th International Scientific Congress on SMA, SMA Europe 2026 (March 11-14, 2026). Event-related materials: https://www.globenewswire.com/Tracker?data=o4gz7XiqoX49QB2C3LdzmcHFwZgCTAiC2nwzYrikq5-6pHyQ3dM0V1wh4zqzIJ3FT2ClxMkIpK80x_m-VA6DBg==

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biogen Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603050730PRIMZONECNPR____9666103) on March 05, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10